AVAILABLE: It's the exact same medication — the authorized generic version of DIASTAT® AcuDial
LEARN MORE

Available:The Authorized Generic With the Same Results as Diastat AcuDial and Lower Patient Co-pay Across the Majority of Plans*

Diazepam Rectal Gel is the authorized generic — the exact same medication as Diastat AcuDial, delivering all the same benefits

  • Proven efficacy in children as young as 2 years of age
    • The ONLY diazepam preparation approved for epilepsy management in people age 2 and up
  • Decades of real-world experience
    • A treatment physicians, parents, and patients have relied on since 1997
  • Confident delivery with precise dosing
    • Available in dial-up delivery system that can be dialed and locked precisely with the prescribed dose

Diazepam Rectal Gel, which is the authorized generic, is the exact same medication as Diastat AcuDial, produced by the same manufacturer—the only difference is the label.

Easy to access for millions of patients with commercial insurance or on Medicaid


More than

79% (135M) of commerically insured patients & 89% (46M) of managed Medicaid patients

have UNRESTRICTED COVERED or PREFERRED ACCESS to Diazepam Rectal Gel nationwide


Learn more about Diastat AcuDial and creating a preparedness plan.

* MMIT data, November 2020. Not all patients are covered. Up to 79% of commercially insured and 89% of managed Medicaid patients had unrestricted or preferred coverage as of November 2020.

All locations for all controllers in the respective channel.

Plans and specific product formulary information are subject to change. Please contact your prescription drug benefit provider for current formulary information.

INDICATION

DIASTAT® (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration for certain patients with epilepsy who are already taking antiepileptic medications, and who require occasional use of diazepam to control bouts of increased seizure activity.

IMPORTANT SAFETY INFORMATION

  • Potentially fatal effects (trouble breathing and sedation) may occur if DIASTAT or DIASTAT AcuDial is used with opioids. Do not use DIASTAT while you are taking opioids unless you are instructed to do so and are supervised by a health care provider.
  • Do not use DIASTAT if you are allergic to diazepam.
  • Do not use DIASTAT if you have an eye condition known as acute narrow angle glaucoma.
  • If you are a caregiver administering DIASTAT, ensure that you have read and understand the Administration and Disposal Instructions section of the DIASTAT full Prescribing Information. Ensure that (1) you can identify the difference between cluster of seizures (and/or the events that precipitate the onset of seizures) from ordinary seizure activity, (2) a doctor confirms that you are able to use the product as instructed, (3) you understand which seizures may or may not be treated with diazepam rectal gel, and (4) you monitor the effect of diazepam rectal gel and know when to seek professional medical help.
  • Do not operate machinery, drive a motor vehicle, or ride a bike until you no longer feel the effects of DIASTAT.
  • Do not use DIASTAT with alcohol or in combination with other Central Nervous System (CNS) medications or products that cause respiratory (breathing) or CNS effects. Talk to your doctor if you have any questions about medications or products that you should not use in combination with DIASTAT.
  • Prolonged sleepiness has been observed in infants treated with diazepam. Therefore, diazepam rectal gel is not recommended for use in children under six months of age.
  • The controlled trials demonstrating the effectiveness of diazepam rectal gel included children two years of age and older. Clinical studies have not been conducted to establish the efficacy and safety of diazepam rectal gel in children under two years of age.
  • Pregnancy Category D - No clinical studies have been conducted with diazepam rectal gel in pregnant women. Data from several sources raise concerns about the use of diazepam during pregnancy. Talk to your doctor before using DIASTAT if you are nursing, pregnant, or of childbearing potential.
  • Use with caution if you have breathing difficulties (such as asthma or pneumonia), kidney or liver disease, or are elderly. Talk to your doctor if any of these conditions apply to you, or if you are not sure if any of these conditions apply to you.
  • Diazepam rectal gel can cause drug addiction. Use no more than every five days and no more than five times per month.
  • The most frequent side effect reported for DIASTAT in clinical trials was somnolence (sleepiness or drowsiness). Other side effects included dizziness, headache, pain, abdominal pain, nervousness, vasodilation (increase in diameter of blood vessel), diarrhea, ataxia/incoordination (lack of coordination), euphoria (feeling of great happiness or well-being), asthma, rhinitis (irritation of the nose similar to an allergy or a cold) and rash.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also contact Bausch Health Companies Inc. Customer Service at 1-800-556-1937.

Please click here for full Prescribing Information including Boxed Warning regarding potentially fatal interactions with opioids.


INDICATIONS AND USAGE

DIASTAT® (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration for certain patients with epilepsy who are already taking antiepileptic medications, and who require occasional use of diazepam to control bouts of increased seizure activity.

IMPORTANT SAFETY INFORMATION

  • Potentially fatal effects (trouble breathing and sedation) may occur if DIASTAT or DIASTAT AcuDial is used with opioids. Do not use DIASTAT while you are taking opioids unless you are instructed to do so and are supervised by a health care provider.
  • Do not use DIASTAT if you are allergic to diazepam.
  • Do not use DIASTAT if you have an eye condition known as acute narrow angle glaucoma.
  • If you are a caregiver administering DIASTAT, ensure that you have read and understand the Administration and Disposal Instructions section of the DIASTAT full Prescribing Information. Ensure that (1) you can identify the difference between cluster of seizures (and/or the events that precipitate the onset of seizures) from ordinary seizure activity, (2) a doctor confirms that you are able to use the product as instructed, (3) you understand which seizures may or may not be treated with diazepam rectal gel, and (4) you monitor the effect of diazepam rectal gel and know when to seek professional medical help.
  • Do not operate machinery, drive a motor vehicle, or ride a bike until you no longer feel the effects of DIASTAT.
  • Do not use DIASTAT with alcohol or in combination with other Central Nervous System (CNS) medications or products that cause respiratory (breathing) or CNS effects. Talk to your doctor if you have any questions about medications or products that you should not use in combination with DIASTAT.
  • Prolonged sleepiness has been observed in infants treated with diazepam. Therefore, diazepam rectal gel is not recommended for use in children under six months of age.
  • The controlled trials demonstrating the effectiveness of diazepam rectal gel included children two years of age and older. Clinical studies have not been conducted to establish the efficacy and safety of diazepam rectal gel in children under two years of age.
  • Pregnancy Category D - No clinical studies have been conducted with diazepam rectal gel in pregnant women. Data from several sources raise concerns about the use of diazepam during pregnancy. Talk to your doctor before using DIASTAT if you are nursing, pregnant, or of childbearing potential.
  • Use with caution if you have breathing difficulties (such as asthma or pneumonia), kidney or liver disease, or are elderly. Talk to your doctor if any of these conditions apply to you, or if you are not sure if any of these conditions apply to you.
  • Diazepam rectal gel can cause drug addiction. Use no more than every five days and no more than five times per month.
  • The most frequent side effect reported for DIASTAT in clinical trials was somnolence (sleepiness or drowsiness). Other side effects included dizziness, headache, pain, abdominal pain, nervousness, vasodilation (increase in diameter of blood vessel), diarrhea, ataxia/incoordination (lack of coordination), euphoria (feeling of great happiness or well-being), asthma, rhinitis (irritation of the nose similar to an allergy or a cold) and rash.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also contact Bausch Health Companies Inc. Customer Service at 1-800-556-1937.

Please click here for full Prescribing Information including Boxed Warning regarding potentially fatal interactions with opioids.

toggle sticky footer menu

INDICATION

DIASTAT® (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration for certain patients with epilepsy who are already taking antiepileptic medications, and who require occasional use of diazepam to control bouts of increased seizure activity.

IMPORTANT SAFETY INFORMATION

  • Potentially fatal effects (trouble breathing and sedation) may occur if DIASTAT or DIASTAT AcuDial is used with opioids. Do not use DIASTAT while you are taking opioids unless you are instructed to do so and are supervised by a health care provider.
  • Do not use DIASTAT if you are allergic to diazepam.
  • Do not use DIASTAT if you have an eye condition known as acute narrow angle glaucoma.
  • If you are a caregiver administering DIASTAT, ensure that you have read and understand the Administration and Disposal Instructions section of the DIASTAT full Prescribing Information. Ensure that (1) you can identify the difference between cluster of seizures (and/or the events that precipitate the onset of seizures) from ordinary seizure activity, (2) a doctor confirms that you are able to use the product as instructed, (3) you understand which seizures may or may not be treated with diazepam rectal gel, and (4) you monitor the effect of diazepam rectal gel and know when to seek professional medical help.
  • Do not operate machinery, drive a motor vehicle, or ride a bike until you no longer feel the effects of DIASTAT.
  • Do not use DIASTAT with alcohol or in combination with other Central Nervous System (CNS) medications or products that cause respiratory (breathing) or CNS effects. Talk to your doctor if you have any questions about medications or products that you should not use in combination with DIASTAT.
  • Prolonged sleepiness has been observed in infants treated with diazepam. Therefore, diazepam rectal gel is not recommended for use in children under six months of age.
  • The controlled trials demonstrating the effectiveness of diazepam rectal gel included children two years of age and older. Clinical studies have not been conducted to establish the efficacy and safety of diazepam rectal gel in children under two years of age.
  • Pregnancy Category D - No clinical studies have been conducted with diazepam rectal gel in pregnant women. Data from several sources raise concerns about the use of diazepam during pregnancy. Talk to your doctor before using DIASTAT if you are nursing, pregnant, or of childbearing potential.
  • Use with caution if you have breathing difficulties (such as asthma or pneumonia), kidney or liver disease, or are elderly. Talk to your doctor if any of these conditions apply to you, or if you are not sure if any of these conditions apply to you.
  • Diazepam rectal gel can cause drug addiction. Use no more than every five days and no more than five times per month.
  • The most frequent side effect reported for DIASTAT in clinical trials was somnolence (sleepiness or drowsiness). Other side effects included dizziness, headache, pain, abdominal pain, nervousness, vasodilation (increase in diameter of blood vessel), diarrhea, ataxia/incoordination (lack of coordination), euphoria (feeling of great happiness or well-being), asthma, rhinitis (irritation of the nose similar to an allergy or a cold) and rash.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also contact Bausch Health Companies Inc. Customer Service at 1-800-556-1937.

Please click here for full Prescribing Information including Boxed Warning regarding potentially fatal interactions with opioids.








 

INDICATION

DIASTAT® (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration for certain patients with epilepsy who are already taking antiepileptic medications, and who require occasional use of diazepam to control bouts of increased seizure activity.

IMPORTANT SAFETY INFORMATION

  • Potentially fatal effects (trouble breathing and sedation) may occur if DIASTAT or DIASTAT AcuDial is used with opioids. Do not use DIASTAT while you are taking opioids unless you are instructed to do so and are supervised by a health care provider.
  • Do not use DIASTAT if you are allergic to diazepam.
  • Do not use DIASTAT if you have an eye condition known as acute narrow angle glaucoma.
  • If you are a caregiver administering DIASTAT, ensure that you have read and understand the Administration and Disposal Instructions section of the DIASTAT full Prescribing Information. Ensure that (1) you can identify the difference between cluster of seizures (and/or the events that precipitate the onset of seizures) from ordinary seizure activity, (2) a doctor confirms that you are able to use the product as instructed, (3) you understand which seizures may or may not be treated with diazepam rectal gel, and (4) you monitor the effect of diazepam rectal gel and know when to seek professional medical help.
  • Do not operate machinery, drive a motor vehicle, or ride a bike until you no longer feel the effects of DIASTAT.
  • Do not use DIASTAT with alcohol or in combination with other Central Nervous System (CNS) medications or products that cause respiratory (breathing) or CNS effects. Talk to your doctor if you have any questions about medications or products that you should not use in combination with DIASTAT.
  • Prolonged sleepiness has been observed in infants treated with diazepam. Therefore, diazepam rectal gel is not recommended for use in children under six months of age.
  • The controlled trials demonstrating the effectiveness of diazepam rectal gel included children two years of age and older. Clinical studies have not been conducted to establish the efficacy and safety of diazepam rectal gel in children under two years of age.
  • Pregnancy Category D - No clinical studies have been conducted with diazepam rectal gel in pregnant women. Data from several sources raise concerns about the use of diazepam during pregnancy. Talk to your doctor before using DIASTAT if you are nursing, pregnant, or of childbearing potential.
  • Use with caution if you have breathing difficulties (such as asthma or pneumonia), kidney or liver disease, or are elderly. Talk to your doctor if any of these conditions apply to you, or if you are not sure if any of these conditions apply to you.
  • Diazepam rectal gel can cause drug addiction. Use no more than every five days and no more than five times per month.
  • The most frequent side effect reported for DIASTAT in clinical trials was somnolence (sleepiness or drowsiness). Other side effects included dizziness, headache, pain, abdominal pain, nervousness, vasodilation (increase in diameter of blood vessel), diarrhea, ataxia/incoordination (lack of coordination), euphoria (feeling of great happiness or well-being), asthma, rhinitis (irritation of the nose similar to an allergy or a cold) and rash.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also contact Bausch Health Companies Inc. Customer Service at 1-800-556-1937.

Please click here for full Prescribing Information including Boxed Warning regarding potentially fatal interactions with opioids.